Skip to main content
TipRanks
Go Ultimate75% OFF

Precision Optics Corporation (POCI) AI Stock Analysis

23 Followers
POCI

Precision Optics Corporation

(NASDAQ:POCI)

Select Model
Rating:48Neutral
Price Target:$5.00â–¼(-4.40% Downside)
Action:reiterated
Date:10/31/26

The overall score of 48 reflects a high-risk, early-stage growth company. The most significant positive factor is the company's demonstrated ability to grow revenue rapidly and improve operational efficiency, as highlighted in the earnings call. However, this is heavily counterbalanced by the critical financial weaknesses of persistent net losses and cash burn, which are the primary drivers of the low score. The near-term guidance for a customer pullback and continued EBITDA losses adds further uncertainty, while the negative P/E ratio and lack of a dividend underscore the speculative nature of the investment.

Positive Factors
Strong Revenue GrowthRapid revenue expansion shows stronger customer adoption and increased production scale across optical systems, micro-optics and related programs. If sustained, the larger revenue base can improve operating leverage, support reinvestment, and strengthen Precision Optics’ position with OEM customers.
Negative Factors
Persistent Cash BurnNegative operating and free cash flow show that the core business is not yet self-funding despite narrower losses and some improvement. Continued cash consumption can constrain investment flexibility and leave the company more dependent on its balance sheet or external funding while profitability is still developing.

Precision Optics Corporation Key Performance Indicators (KPIs)

Revenue by SegmentBreaks down revenue by different business segments, highlighting which parts of the company are driving growth and profitability, and where there might be challenges or opportunities for expansion.

$0.00$1.00M$2.00M$3.00M$4.00M$5.00M$6.00MMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25
Chart Insights

Precision Optics Corporation's Engineering Design Services segment experienced a significant revenue decline after a peak in early 2024, indicating potential challenges in maintaining client demand or project completions. Conversely, Optical Components show resilience with consistent growth, suggesting strong market demand or successful product innovations. The Medical Device Products & Assemblies segment is facing a downturn, possibly due to competitive pressures or market saturation. The absence of revenue from Systems Manufacturing and Technology Rights highlights a focus on core segments. Investors should watch for strategic pivots or new initiatives to drive growth.

Data provided by:The Fly

Precision Optics Corporation (POCI) vs. SPDR S&P 500 ETF (SPY)

-20%-10%0%10%20%30%40%POCI+15.71%SPY+14.55%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$57.39M
Dividend Yield
―
Average Volume (3M)
44.05K
Price to Earnings (P/E)
-11.3
Beta (1Y)
0.29
Revenue Growth
65.16%
EPS Growth
45.07%
Country
US
Employees
108
Sector
Healthcare
Sector Strength
51
Industry
Medical - Instruments & Supplies

Precision Optics Corporation Business Overview & Revenue Model

Company Description

Precision Optics Corporation, Inc. (POCI) specializes in the engineering, manufacturing, and sale of advanced optical and illumination systems, along with their complementary components. Its main operational regions are the United States and the Euro...

Precision Optics Corporation Earnings Call Summary

Earnings Call Date:Sep 28, 2026(Q4-2026)|% Change Since:15.58%|Next Earnings Date:Nov 14, 2024
Earnings Call SentimentPositive

The call was broadly positive, supported by record fourth-quarter and full-year revenue, sharply improved production efficiency, positive adjusted EBITDA in the second half, stronger yields, new satellite and defense opportunities, and a strengthened balance sheet. The main negative factors were the expected 40% first-quarter fiscal 2027 revenue reduction from the existing satellite customer, further second-quarter reduction, lower engineering revenue, an expected fiscal 2027 adjusted EBITDA loss, and the uncertainty surrounding the timing of satellite program recovery and new program production.

Positive Updates

Record Fourth-Quarter and Full-Year Revenue
Fourth-quarter revenue reached a record $8.8 million, up approximately 42% from $6.2 million a year ago and slightly above $8.7 million in the sequential third quarter. Full-year revenue increased approximately 65% to $31.5 million from $19.1 million, exceeding the company's most recent guidance.

Negative Updates

Temporary Existing Satellite Customer Pullback
The existing satellite customer is expected to reduce production, with revenue anticipated to decline 40% in the first quarter of fiscal 2027 and decrease further in the second quarter. Management attributed the reduction to excess inventory caused by constrained worldwide satellite launch capacity and said the timing and extent of recovery remain uncertain, although the most recent communications indicate recovery by the end of fiscal 2027.

Company Guidance

For fiscal 2027, Precision Optics expects revenue of $30 million to $33 million, similar to fiscal 2026, and adjusted EBITDA to range from negative $1.2 million to negative $1.7 million, with quarterly losses early in the year before a return to quarterly profitability by the end of the year; the existing satellite customer is expected to have an anticipated 40% reduction in revenue in the first quarter of fiscal 2027 and an additional reduction in the second quarter, with a recovery by the end of fiscal 2027, while the new satellite customer’s stated goal is to begin production within approximately 6 to 12 months with a potential significant impact to our fourth fiscal quarter in fiscal 2027, and initial production orders are expected to have a similar 2- to 4-month supply chain start-up; the single-use endoscope market estimates are still 10% to 20% per year, with the Unity platform expected to bring development-to-production timing down to 1 to 2 years.

Precision Optics Corporation Financial Statement Overview

Summary

Financial performance is a tale of two stories. The 65% revenue surge to $31.5M is a clear strength, but it is overshadowed by persistent net losses, compressed gross margins of 17.2%, and significant cash burn with negative $2.0M in free cash flow. The balance sheet is stable due to equity issuance, providing a runway, but the company is not yet generating returns on its capital, making this a high-risk, pre-profitability profile.

Income Statement

28Negative

Balance Sheet

55Neutral

Cash Flow

30Negative
Financial statement breakdown
BreakdownTTMJun 2026Jun 2025Sep 2024Jun 2023Jun 2022
Income Statement
Total Revenue31.53M31.53M19.09M19.10M21.04M15.68M
Gross Profit5.43M5.43M3.40M5.80M7.73M4.93M
EBITDA-3.23M-3.20M-5.34M-2.51M286.99K-581.59K
Net Income-3.63M-3.63M-5.78M-2.95M-144.61K-928.42K
Balance Sheet
Total Assets32.34M32.34M19.79M16.91M19.74M16.70M
Cash, Cash Equivalents and Short-Term Investments9.84M9.84M1.77M405.28K2.93M605.75K
Total Debt4.06M4.06M2.04M3.43M3.16M3.00M
Total Liabilities11.99M11.99M7.53M6.84M7.69M7.73M
Stockholders Equity20.35M20.35M12.26M10.07M12.05M8.97M
Cash Flow
Free Cash Flow-1.98M-1.98M-3.77M-2.98M-133.59K-1.09M
Operating Cash Flow-1.55M-1.55M-3.55M-2.68M-81.09K-933.37K
Investing Cash Flow-429.35K-429.35K-233.47K-293.88K-52.50K-407.80K
Financing Cash Flow10.05M10.05M5.15M456.32K2.45M1.09M

Precision Optics Corporation Technical Analysis

Technical Analysis SentimentPositive
Last Price5.23

Price Trends

50DMA4.53Positive
100DMA4.52Positive
200DMA4.63Positive

Market Momentum

MACD0.18Negative
RSI70.57Negative
STOCH60.66Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For POCI, the sentiment is Positive. The current price of 5.23 is above the 20-day moving average (MA) of 4.66, above the 50-day MA of 4.53, and above the 200-day MA of 4.63, indicating a bullish trend. The MACD of 0.18 indicates Negative momentum. The RSI at 70.57 is Negative, neither overbought nor oversold. The STOCH value of 60.66 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for POCI.

Precision Optics Corporation Risk Analysis

Precision Optics Corporation disclosed 32 risk factors in its most recent earnings report. Precision Optics Corporation reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

2 New Risks
1.Changes in U.S. Tariff Policy and Related Trade Actions Could Adversely Affect Our International Supply Chain, Costs, and Competitive PositionQ2, 2025
2.Changes in U.S. Tariff Policy and Related Trade Actions Could Adversely Affect Our International Supply Chain, Costs, and Competitive PositionQ1, 2025

Precision Optics Corporation Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

POCI against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
POCIPOCI48Neutral$57.39M-11.29-23.92%―65.16%45.07%
MLSSMLSS44Neutral$27.83M-7.36-122.29%―3.93%48.18%
RVPRVP44Neutral$16.76M-4.65-4.59%―-11.16%59.85%
FEMYFEMY43Neutral$11.89M-0.46-114.48%―-4.21%78.58%
NXGLNXGL40Underperform$11.92M-0.27-133.10%―3.38%-78.48%

* Healthcare Sector Average

Performance Comparison

-50%0%50%POCIRVPMLSSFEMYNXGLDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
POCI and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
POCIPrecision Optics Corporation, Inc.5.230.9020.79%
RVPRetractable Technologies0.56-0.27-32.89%
MLSSMilestone Scientific Inc0.31-0.01-1.60%
FEMYFemasys, Inc.1.42-14.51-91.08%
NXGLNexgel, Inc.3.88-32.92-89.46%

Precision Optics Corporation Corporate Events

Business Operations and StrategyRegulatory Filings and Compliance

Precision Optics Signs New Facility Lease Agreement

Positive
Oct 30, 2026

On October 28, 2026, Precision Optics Corporation, Inc. entered into a new lease agreement with Equity Assets, Inc. for its existing facility at 22-28 East Broadway in Gardner, Massachusetts, covering approximately 12,292 rentable square feet of comm...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 30, 2026